share_log

小摩:维持Kiniksa Pharmaceuticals(KNSA.US)评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。

Zhitong Finance ·  May 1 10:55

小摩:维持Kiniksa Pharmaceuticals(KNSA.US)评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment